CKD: Clinical Trials

83 trials for CKD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 unknown, 21 recruiting, 20 completed, 6 not yet recruiting. 26 Not applicable, 6 Phase 4, 5 Phase 2, 5 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable26Recruiting 8, Completed 7, Unknown 6, Active not recruiting 2, Enrolling by invitation 2, Not yet recruiting 1
Phase 46Completed 2, Not yet recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 25Recruiting 2, Completed 1, Terminated 1, Unknown 1
Phase 35Terminated 2, Unknown 2, Recruiting 1
Early Phase 11Unknown 1
Phase 11Recruiting 1

Follow CKD: new trials by email Literature Review of CKD trials Research Report on CKD

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access
Semaglutide, Virtual Weight Management Coaching - Obesity, Chronic Kidney Disease
Phase 4Not yet recruitingKristin Clemens8802027-01-012026-10-05
Effects of Dietary Phosphorus on Phosphorus and Calcium Whole-Body Balance and Kinetics in Moderate CKD
LP then HP, HP then LP - CKD
Not applicableNot yet recruitingUniversity of Minnesota142026-11-012026-10-02
Predictors of Rapid CKD Progression
Chronic Kidney Diseases, Kidney Failure
Not yet recruitingAssiut University1902026-09-012026-09-03
A Multimodal Integrated Intervention for Kidney Cachexia
Multi-Modal Integrated Intervention Combining Exercise, Anti-inflammatory & Dietary Advice (MMIEAD) - Cachexia, CKD
Not applicableRecruitingQueen's University, Belfast402026-09-012026-08-26
A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.
HTD1801, placebo - T2DM, CKD
Phase 2RecruitingInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences752026-07-092026-07-15
Hyperlipoproteinemia A as a Marker of Cardiovascular Risk in Patients With Stage 4 Chronic Kidney Disease
lipoprotein A level dosing - CKD, Cardiovascular Diseases
RecruitingCentre Hospitalier Universitaire de Nīmes3002026-07-012026-10-20
Self-Management Data and Disease Progression in Chronic Kidney Disease
CKD Self-Management Mobile Application - Chronic Kidney Disease, CKD
RecruitingChungnam National University Hospital3002026-06-112026-08-10
Adia Med of Winter Park LLC Chronic Kidney Disease Research Study
Umbilical Cord Blood-Derived Stem Cells and Exosomes, Glutathione IV, Glutathione Spray - Chronic Kidney Disease, Kidney Disease
Phase 1RecruitingAdia Med of Winter Park LLC1002026-05-182026-06-17
Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity
Digital Care Community Common Good Program, Usual Care - Type2Diabetes, Hypertension
Not applicableRecruitingChang Gung University of Science and Technology1692026-05-122026-08-21
Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
vicadrostat / empagliflozin combination 1, Spironolactone (drug) - CKD, Cardiovascular Diseases
Phase 2RecruitingUniversity Medical Center Groningen1002026-05-122026-05-29
Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)
Observational assessment - Periodontal Disease, Periodontitis
RecruitingStefan Lujinschi1002026-05-042026-06-26
Fostering Self-Empowerment in CKD Patients Through Food Choice Mapping
Mobile application empowerment approach - CKD, Chronic Kidney Disease (Stages 3b-5)
RecruitingSingapore Institute of Technology302026-04-152026-09-04
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
Veverimer, Placebo - CKD, Metabolic Acidosis
Phase 3RecruitingRenibus Therapeutics, Inc.1502026-01-132026-10-23
The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations
CKD, Renal Insufficiency Chronic
RecruitingUniversity of Copenhagen502025-12-152025-12-31
Effect of Roxadustat on Heart Failure Patients With Anaemia and Moderate-to-Severe Chronic Kidney Disease
Roxadustat - Heart Failure, CKD
Not yet recruitingZhongda Hospital2002025-12-012025-12-08
Impact of Garlic on the Clinical Outcome in Chronic Hemodialysis Patients
Dried garlic powder (Garlic extract) - Allium sativum. - Hemodialysis, Endothelial Dysfunction
Not applicableCompletedAin Shams University582025-10-012026-03-10
Suitability of a High-energy, Low-protein Formula (Renalive® LP)
Renalive® LP, - CKD, Low Protein Dietary Intake
Not applicableRecruitingFresenius Kabi Taiwan Ltd.802025-06-042026-10-01
Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery
Salt substitute - Kidney Tumors, CKD
Not applicableRecruitingJinling Hospital, China2002025-04-242025-12-15
Real-World Study of Enarodustat for Anemia in Non-Dialysis CKD Patients
Enarodustat - Anemia of Chronic Kidney Disease, CKD
RecruitingHuashan Hospital902025-03-232026-08-03
Chronic Kidney Disease in Pregnant Females
Participants are not assigned an intervention as a part of the study - CKD
Not yet recruitingAssiut University4972024-12-012024-12-17

Showing 20 of 83. Sign in to see all of them.

Narrower conditions

Renal Insufficiency, Chronic (18)  ·  Diabetes Mellitus (10)  ·  COVID-19 (7)  ·  Hypertension (7)  ·  Kidney Failure, Chronic (7)  ·  Cardiovascular Diseases (6)  ·  Diabetes Mellitus, Type 2 (6)  ·  Heart Failure (6)  ·  Obesity (6)  ·  Anemia (5)  ·  Acidosis (4)  ·  Inflammation (4)  ·  Pulmonary Disease, Chronic Obstructive (4)  ·  Renal Insufficiency (4)  ·  Acute Kidney Injury (3)

Broader conditions

Pathological Conditions, Signs and Symptoms (38)  ·  Pathologic Processes (33)  ·  Female Urogenital Diseases (30)  ·  Female Urogenital Diseases and Pregnancy Complications (30)  ·  Urogenital Diseases (30)  ·  Male Urogenital Diseases (29)  ·  Urologic Diseases (29)  ·  Disease Attributes (28)  ·  Chronic Disease (27)  ·  Nutritional and Metabolic Diseases (27)  ·  Kidney Diseases (26)  ·  Metabolic Diseases (24)  ·  Renal Insufficiency (23)  ·  Endocrine System Diseases (19)  ·  Glucose Metabolism Disorders (15)

Interventions

Probiotics (3)  ·  dapagliflozin (3)  ·  Lactulose (2)  ·  semaglutide (2)  ·  Absorptiometry, Photon (1)  ·  Anti-Inflammatory Agents (1)  ·  Contraceptives, Oral (1)  ·  Cooking (1)  ·  Decision Support Techniques (1)  ·  Digital Technology (1)  ·  Dosage Forms (1)  ·  Echocardiography (1)  ·  Erythropoietin (1)  ·  Exercise Therapy (1)  ·  Fecal Microbiota Transplantation (1)

Sponsors

Assiut University (12)  ·  National Taiwan University Hospital (3)  ·  University Medical Center Groningen (3)  ·  Eurasian Association of Therapists (2)  ·  University of Copenhagen (2)  ·  Adia Med of Winter Park LLC (1)  ·  Affiliated Hospital of Qinghai University (1)  ·  Ain Shams University (1)  ·  Alexion Pharmaceuticals, Inc. (1)  ·  Bangkok Metropolitan Administration Medical College and Vajira Hospital (1)  ·  Barts & The London NHS Trust (1)  ·  Baylor Research Institute (1)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  Chang Gung University of Science and Technology (1)  ·  China Medical University, Taiwan (1)

Countries

United States (16)  ·  China (10)  ·  Taiwan (8)  ·  Italy (6)  ·  Spain (6)  ·  United Kingdom (6)  ·  Denmark (5)  ·  Netherlands (5)  ·  Canada (4)  ·  Egypt (4)  ·  France (3)  ·  Romania (3)  ·  South Korea (3)  ·  Germany (2)  ·  India (2)

Top investigators

Adrian C Covic, Professor (1)  ·  Aleksander Arutyunov, MD, PhD (1)  ·  Alex R Chang, MD, MS (1)  ·  Alexander Arutyunov, professor (1)  ·  Amira Kassem, BPharm, MS, PhD (1)  ·  Andrea Oliverio, MD, MSc (1)  ·  Annie Jones, PhD (1)  ·  Asmaa Ahmed, lecture (1)  ·  Bahtiar Ismail, MD, PhD (1)  ·  Chun-Pai Yang, MD (1)  ·  Donald Wesson, MD, MBA (1)

Results publications

PMID 17167242, PMID 22067929, PMID 22172001, PMID 22924055, PMID 23024693, PMID 24159343, PMID 24311851, PMID 24716178, PMID 27313640, PMID 28469156, PMID 30276600, PMID 30694615, PMID 30909513, PMID 31142774, PMID 31860056, PMID 31899053, PMID 32775838, PMID 33655979, PMID 33754024, PMID 34614411, PMID 34713782, PMID 35524223, PMID 35529086, PMID 35581444, PMID 35986026, PMID 36286918, PMID 37858212, PMID 38046912, PMID 38273240, PMID 38713047, PMID 39897388, PMID 40008278, PMID 40448185, PMID 40650408, PMID 41160422, PMID 41308049, PMID 41580107, PMID 41715172, PMID 42530392, PMID 42819749

NIH funding

2023 (1), 2025 (1), I01CX001449 (1), K23DK123413 (1), K23DK125840 (1)